{"body":"<p>1. Malaria elimination. A field manual for low and moderate endemic countries. Geneva: World Health organization; 2007 (<a href=\"https:\/\/apps.who.int\/iris\/\">http:\/\/apps.who.int\/iris\/bitstream\/10665\/43796\/1\/9789241596084_eng.pdf<\/a>, accessed 3 February 2017).<\/p>&#13;\n&#13;\n<p>2. Control and elimination of <em>Plasmodium<\/em> <em>vivax<\/em>: a technical brief. Geneva: World Health Organization; 2015 (<a href=\"https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/181162\/9789241509244_eng.pdf\">https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/181162\/9789241509244_eng.pdf<\/a>, accessed 2 May 2016).<\/p>&#13;\n&#13;\n<p>3. World malaria report 2016. Geneva: World Health Organization; 2016.<\/p>&#13;\n&#13;\n<p>4. Achieving the malaria Millennium Development Goal target: reversing the incidence of malaria 2000\u20132015. Geneva: WHO and UNICEF; 2015 (<a href=\"https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/184521\/9789241509442_eng.pdf?sequence=1\">http:\/\/apps.who.int\/iris\/bitstream\/10665\/184521\/1\/9789241509442_eng.pdf<\/a>, accessed 2 May 2016).<\/p>&#13;\n&#13;\n<p>5. Global technical strategy for malaria 2016\u20132030. Geneva: World Health Organization; 2015 (<a href=\"https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/176712\/9789241564991_eng.pdf?sequence=1\">http:\/\/apps.who.int\/iris\/bitstream\/10665\/176712\/1\/9789241564991_eng.pd<\/a>f, accessed 2 May 2016).<\/p>&#13;\n&#13;\n<p>6. Action and investment to defeat malaria 2016\u20132030 (AIM). Geneva: World Health Organization; 2015 <a href=\"https:\/\/endmalaria.org\/resources\">(http:\/\/www.rollbackmalaria.org\/files\/files\/aim\/RBM_AIM_ Report_A4_EN-Sept2015.pdf, accessed 6 July 2016).<\/a><\/p>&#13;\n&#13;\n<p>7. WHO policy recommendation on malaria diagnostics in low transmission settings. Geneva: World Health Organization; 2014 (<a href=\"https:\/\/www.who.int\/malaria\/en\/\">http:\/\/www.who.int\/malaria\/ publications\/atoz\/who-recommendation-diagnostics-low-transmission-settingsmar2014.pdf, accessed 3 February 2017). <\/a><\/p>&#13;\n&#13;\n<p>8. Guidelines for the treatment of malaria. Third edition. Geneva: World Health Organization; 2015 (<a href=\"http:\/\/apps.who.int\/iris\/bitstream\/10665\/162441\/1\/9789241549127_eng.pdf\">http:\/\/apps.who.int\/iris\/ bitstream\/10665\/162441\/1\/9789241549127_eng.pdf<\/a>, accessed 3 February 2017).<\/p>&#13;\n&#13;\n<p>9. The role of mass drug administration, mass screening and treatment, and focal screening and treatment for malaria. Recommendations. Geneva: World Health Organization; 2015 (<a href=\"https:\/\/www.who.int\/malaria\/publications\/atoz\/role-of-mda-for-malaria.pdf\">http:\/\/www.who.int\/malaria\/publications\/atoz\/role-of-mda-for-malaria.pdf<\/a>, accessed 3 February 2017).<\/p>&#13;\n&#13;\n<p>10. Risks associated with scale-back of vector control after malaria transmission has been reduced. Information note. Geneva: World Health Organization; 2015 (<a href=\"https:\/\/www.who.int\/malaria\/publications\/atoz\/scale-back-vector-control.pdf?ua=1\">http:\/\/ www.who.int\/malaria\/publications\/atoz\/scale-back-vector-control.pdf<\/a>, accessed 3 February 2017).<\/p>&#13;\n&#13;\n<p>11. Cox J, Sovannaroth S, Soley LD, Ngor P, Mellor S, Roca-Feltrer A. Novel approaches to risk stratification to support malaria elimination: an example from Cambodia. Malar J 2014;13:1.<\/p>&#13;\n&#13;\n<p>12. The malERA Consultative Group on Monitoring, Evaluation, and Surveillance. A research agenda for malaria eradication: monitoring, evaluation, and surveillance. PLoS Med 2011;8:e1000400.<\/p>&#13;\n&#13;\n<p>13. Moonen B, Cohen JM, Snow RW, Slutsker L, Drakeley C, Smith DL, et al. Operational strategies to achieve and maintain malaria elimination. Lancet 2010;376:1592\u20131603.<\/p>&#13;\n&#13;\n<p>14. Hennekens C, Buring J. Epidemiology in medicine. Philadelphia, PA: Lippincott Williams and Wilkins; 1987:57.<\/p>&#13;\n&#13;\n<p>15. Yekutiel P. Problems of epidemiology in malaria eradication. Bull World Health Organ 1960;22:669\u2013683.<\/p>&#13;\n&#13;\n<p>16. Cameron E, Battle KE, Bhatt S, Weiss DJ, Bisanzio D, Mappin B, et al. Defining the relationship between infection prevalence and clinical incidence of <em>Plasmodium<\/em> <em>falciparum<\/em> malaria. Nature Commun 2015;8:8170.<\/p>&#13;\n&#13;\n<p>17. Cohen JM, Moonen B, Snow RW, Smith DL. How absolute is zero? An evaluation of historical and current definitions of malaria elimination. Malar J 2010;9:213.<\/p>&#13;\n&#13;\n<p>18. Malaria rapid diagnostic test performance: results of WHO product testing of malaria RDTs: round 6 (2014\u20132015). Geneva: World Health Organization; 2015 (<a href=\"https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/204118\/9789241510035_eng.pdf?sequence=1\">http:\/\/apps.who.int\/iris\/bitstream\/10665\/204118\/1\/9789241510035_eng.pdf<\/a>, accessed 10 February 2017).<\/p>&#13;\n&#13;\n<p>19. WHO recommendations for achieving universal coverage with long-lasting insecticidal nets in malaria control. Geneva: World Health Organization; 2013.<\/p>&#13;\n&#13;\n<p>20. Estimating population access to ITNs versus quantifying for procurement for mass campaigns. Geneva: World Health Organization; 2014 <a href=\"https:\/\/www.who.int\/malaria\/en\/\">(www.who.int\/malaria\/ publications\/atoz\/who-clarification-estimating-population-access-itn-mar2014. pdf<\/a>, accessed 3 February 2017).<\/p>&#13;\n&#13;\n<p>21. WHO guidance for countries on combining indoor residual spraying and longlasting insecticidal nets. Geneva: World Health Organization; 2014; (<a href=\"https:\/\/www.who.int\/malaria\/publications\/atoz\/who-guidance-combining-irs_llins-mar2014\">http:\/\/www. who.int\/malaria\/publications\/atoz\/who-guidance-combining-irs_llins-mar2014. pdf<\/a>, accessed 3 February 2017).<\/p>&#13;\n&#13;\n<p>22. Control of residual malaria parasite transmission: guidance note. Geneva: World Health Organization; 2014 (<a href=\"http:\/\/www.who.int\/malaria\/publications\/atoz\/technical-note-control-of-residual-malaria-parasite-transmission-sep14.pdf\">http:\/\/www.who.int\/malaria\/publications\/atoz\/technical-note-control-of-residual-malaria-parasite-transmission-sep14.pdf<\/a>, accessed 3 February 2017).<\/p>&#13;\n&#13;\n<p>23. Larval source management \u2013 a supplementary measure for malaria vector control. An operational manual. Geneva: World Health Organization; 2013.<\/p>&#13;\n&#13;\n<p>24. Supplementary vector control methods. Geneva: World Health Organization; 2015; (<a href=\"https:\/\/www.who.int\/malaria\/areas\/vector_control\/complementary_methods\/en\/\">http:\/\/www.who.int\/malaria\/areas\/vector_control\/complementary_methods\/ en\/<\/a>, accessed 3 February 2017).<\/p>&#13;\n&#13;\n<p>25. Hay SI, Smith DL, Snow RW. Measuring malaria endemicity from intense to interrupted transmission. Lancet Infect Dis 2008;8;369\u2013378.<\/p>&#13;\n&#13;\n<p>26. WHO Evidence Review Group on Malaria Diagnosis in Low Transmission Settings. WHO Headquarters, Geneva, 16\u201318 December 2013. Meeting report. Geneva: World Health Organization; 2013 <a href=\"https:\/\/www.who.int\/malaria\/mpac\/mpac_\">(<\/a><a href=\"http:\/\/www.who.int\/malaria\/mpac\/mpac_mar2014_diagnosis_low_transmission_settings_report.pdf\">http:\/\/www.who.int\/malaria\/mpac\/mpac_mar2014_diagnosis_low_transmission_settings_report.pdf<\/a>, accessed 3 February 2017).<\/p>&#13;\n&#13;\n<p>27. Policy brief on single-dose primaquine as a gametocytocide in <em>Plasmodium<\/em> <em>falciparum<\/em> malaria (WHO\/HTM\/GMP\/2015.1). Geneva: World Health Organization; 2015 (<a href=\"https:\/\/www.who.int\/malaria\/publications\/atoz\/who_htm_gmp_2015.1.pdf\">http:\/\/www.who.int\/malaria\/publications\/atoz\/who_htm_gmp_2015.1.pdf<\/a>, accessed 3 February 2017).<\/p>&#13;\n&#13;\n<p>28. Functions and minimum standards for national reference laboratories in the SADC region. Gaborone: Southern African Development Community; 2009.<\/p>&#13;\n&#13;\n<p>29. Universal access to malaria diagnostic testing \u2013 an operational manual. Geneva: World Health Organization; 2011.<\/p>&#13;\n&#13;\n<p>30. Management of quality of care: quality assurance. Geneva: World Health Organization; 2017 <a href=\"https:\/\/www.who.int\/management\/quality\/assurance\/en\/\">(http:\/\/www.who.int\/management\/quality\/assurance\/en\/). <\/a><\/p>&#13;\n&#13;\n<p>31. Policy and procedures of the WHO\/NICD Microbiology External Quality Assessment Programme in Africa years 1 to 4, 2002\u20132006 (WHO\/CDS\/EPR\/ LYO\/2007.3). Geneva: World Health Organization; 2007 (<a href=\"https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/69696\/WHO_CDS_EPR_LYO_2007.3_eng.pdf?sequence=1\">http:\/\/whqlibdoc.who.int\/hq\/2007\/WHO_CDS_EPR_LYO_2007.3_eng.pdf<\/a>, accessed 3 February 2017).<\/p>&#13;\n&#13;\n<p>32. Disease surveillance for malaria elimination: operational manual. Geneva: World Health Organization; 2012 (<a href=\"https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/44852\/9789241503334_eng.pdf?sequence=1\">http:\/\/apps.who.int\/iris\/bitstream\/10665\/44852\/1\/9789241503334_eng.pdf<\/a>, accessed 3 February 2017).<\/p>&#13;\n&#13;\n<p>33. Disease surveillance for malaria control: operational manual. Geneva: World Health Organization; 2012 <a href=\"https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/44851\/9789241503341_?sequence=1\">(http:\/\/apps.who.int\/iris\/bitstream\/10665\/44851\/1\/9789241503341_eng.pdf<\/a>, accessed 3 February 2017).<\/p>&#13;\n&#13;\n<p>34. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of eighth biannual meeting (September 2015). Malar J 2016;15:117.<\/p>&#13;\n&#13;\n<p>35. Newby G, Hwang J, Koita K, Chen I, Greenwood B, von Seiflein L, et al. Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg 2015;93:125\u2013134.<\/p>&#13;\n&#13;\n<p>36. Taylor CE, Waldman RJ. Designing eradication programs to strengthen primary health care. Chapter 13, in: Dowdle WR, Hopkins DR, editors. The eradication of infectious diseases. Hoboken, NJ: John Wiley &amp; Sons Ltd; 1998:145\u2013155.<\/p>&#13;\n&#13;\n<p>37. Gonz\u00e1lez-Silva M, Bassat Q, Alonso PL. Getting ready for malaria elimination: a check list of critical issues to consider. Mem Inst Oswaldo Cruz 2014;109:517\u2013521.<\/p>&#13;\n&#13;\n<p>38. Cochi SL, and Dowdle WR, editors. Disease eradication in the 21st century: implications for global health. Boston, MA: MIT Press; 2011.<\/p>&#13;\n&#13;\n<p>39. The malERA Consultative Group on Health Systems and Operational Research. A research agenda for malaria eradication: health systems and operational research. PLoS Med 2011;8:e1000397.<\/p>&#13;\n&#13;\n<p>40. Alonso PL, Brown G, Arevalo-Herrera M, Binka F, Chitnis C, Collins F, et al. A research agenda to underpin malaria eradication. PLoS Med 2011;8:e1000406.<\/p>&#13;\n&#13;\n<p>41. Smith DL, Cohen JM, Chiyaka C, Johnston G, Gething PW, Gosling R, et al. A sticky situation: the unexpected stability of malaria elimination. <em>Philos Trans R Soc B Biol Sci<\/em> 2013;368:20120145.<\/p>&#13;\n&#13;\n<p>42. Overview of malaria elimination. Geneva: World Health Organization; 2016 (<a href=\"https:\/\/www.who.int\/malaria\/areas\/elimination\/overview\/en\/\">http:\/\/www.who.int\/malaria\/areas\/elimination\/overview\/en\/<\/a>, accessed 3 February 2017).<\/p>&#13;\n","title":"References","nid":364,"vid":2878,"created":1567506672,"changed":1581947983,"field_content_type":{"tid":2,"name":"Content","class":"content"},"field_references":null}